Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225

Oncogene

Volumn 18, Issue 3, 1999, Pages 731-738

  Ye, Dingwei ^a   Mendelsohn, John ^a   Fan, Zhen ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

CDK; Cell cycle; EGF receptor; HER2; mAb; p27(Kip1)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN P27;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FEMALE; G1 PHASE; GROWTH INHIBITORS; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033590602     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202319     Document Type: Article

References (39)

1. Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC and Norton L. (1996). J. Clin. Oncol., 14, 737-744.
2. Bos M, Mendelsohn J, Bowden C, Pfister D, Cooper MR, Cohen R, Burtness B, D'Andrea G, Waksal H, Norton L and Baselga J. (1996). Proc. Am. Clin. Oncol., 15, 443.
3. Chou JL, Fan Z, Koff A and Mendelsohn J. (1996). Proc. Am. Assoc. Cancer Res., 37, 10.
4. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Paton V, Shak S, Lieberman G and Slamon D. (1998). Proc. Am. Clin. Oncol., 17, 97a.
5. Divgi CR, Welt C, Kris M, Real FX, Yeh SDJ, Gralla R, Merchant B, Schweighart S, Unger M, Larson SM and Mendelsohn J. (1991). J. Natl. Cancer Inst., 83, 97-104.
6. Earp HS, Dawson TL, Li X and Yu H. (1995). Breast Cancer Res. Treat., 35, 115-132.
7. Fan Z, Lu Y, Wu X, DeBlasio A, Koff A and Mendelsohn J. (1995). J. Cell. Biol., 131, 235-242.
8. Fan Z, Lu Y, Wu X and Mendelsohn J. (1994). J. Biol. Chem., 269, 27595-27602.
9. Fan Z, Mendelsohn J, Masui H and Kumar R. (1993). J. Biol. Chem., 268, 21073-21079.
10. Fan Z, Shang BY, Lu Y, Chou JL and Mendelsohn J. (1997). Clin. Cancer Res., 3, 1943-1948.
11. Fan Z and Mendelsohn J. (1998). Curr. Opin. Onco., 10, 67-73.
12. Falcey J, Pfister D, Cohen R, Cooper M, Bowden C, Burtness B, Mendelsohn J and Waksal H. (1997). Proc. Am. Soc. Clin. Oncol., 16, 383a.
13. Goldman R, Levy RB, Peles E and Yarden Y. (1990). Biochem., 29, 11024-11028.
14. Goldstein NI, Prewett M, Zuklys K, Rockwell P and Mendelsohn J. (1995). Clin. Cancer Res., 1, 1311-1318.
15. Harris AL, Nicholson S, Stainsbury JR, Farndon JR and Wright C. (1989). J. Steroid Biochem., 34, 123-131.
16. Jardines L, Weiss M, Fowble B and Greene M. (1993). Pathobiology, 61, 268-282.
17. Kawamoto T, Sato JD, Le A, Sato GH and Mendelsohn J. (1983). Proc. Natl. Acad. Sci. USA, 80, 1337-1341.
18. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM and Massague J. (1990). Cell, 62, 175-185.
19. Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C and Shepard HM. (1993). Cancer Immunol. Immunother., 37, 255-263.
20. Mendelsohn J. (1990). Sem. Cancer Biol., 1, 339-344.
21. Morgan DO. (1995). Nature, 374, 131-134.
22. Pegram M, Lipton A, pietras R, Hayes D, Weber B, Baselga J, tripathy D, Twaddell T, Glaspy J and Slamon D. (1995). Proc. Am. Soc. Clin. Oncol., 14, 106.
23. Peles E, Ben-levy R, Tzahar E, Liu N, Wen D and Yarden Y. (1993). EMBO J., 12, 961-971.
24. Peng D, Fan Z, Lu Y, DeBlasio T, Scher H and Mendelsohn J. (1996). Cancer Res., 56, 3666-3669.
25. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM and Buckley S. (1993). Nature, 366, 473-475.
26. Prewett M, Rockwell P, Rockwell RF, Giorgio NA, Mendelsohn J, Scher H and Goldstein NI. (1996). J. Immunother., 19, 419-427.
27. Qian X, LeVea CM, Freeman JK, Dougall WC and Greene MI. (1994). Proc. Natl. Acad. Sci. USA, 91, 1500-1504.
28. Reese DM and Slamon DJ. (1997). Stem Cells, 15, 1-8.
29. Sherr CJ. (1996). Science, 274, 1672-1677.
30. Scott GK, Dodson JM, Montgomery PA, Johnson RM, Sarup JC, Wong WL, Ullrich A, Shepard HM and Benz CC. (1991). J. Biol. Chem., 266, 14300-14305.
31. Shott S. (1990). Statistics for Health Professionals. Eoyang T. (ed.). W.B. Saunders Company Press: Philadelphia. pp. 151-154.
32. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
33. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. (1989). Science. 244, 707-712.
34. Slamon D, Leyland-Jones B, Shak S, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Baselga J and Norton L. (1998). Proc. Am Clin. Oncol., 17, 98a.
35. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL and Carraway KLIII. (1994). J. Biol. Chem., 269, 14661-14665.
36. Stern DF and Kamps MP. (1988). EMBO J., 7, 995-1001.
37. Ullrich A and Schlessinger J. (1990). Cell, 61, 203-212.
38. Wada T, Qian XL and Greene MI. (1990). Cell, 61, 1339-1347.
39. Wu X, Rubin M, Fan Z, DeBlasio T, Soos T, Koff A and Mendelsohn J. (1996). Oncogene, 12, 1397-1403.